Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 98; pp. 501 - 502
Main Authors Petersen, Eskild, Wejse, Christian, Zumla, Alimuddin
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.09.2020
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Online AccessGet full text

Cover

Author Petersen, Eskild
Wejse, Christian
Zumla, Alimuddin
Author_xml – sequence: 1
  givenname: Eskild
  surname: Petersen
  fullname: Petersen, Eskild
  email: eskild.petersen@gmail.com
  organization: Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark
– sequence: 2
  givenname: Christian
  surname: Wejse
  fullname: Wejse, Christian
  email: wejse@ph.au.dk
  organization: Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
– sequence: 3
  givenname: Alimuddin
  surname: Zumla
  fullname: Zumla, Alimuddin
  email: a.i.zumla@gmail.com
  organization: Center for Clinical Microbiology, Division of Infection and Immunity, University College London, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32822866$$D View this record in MEDLINE/PubMed
BookMark eNqFUktvEzEQXqEi-oA_wAHtkcsGv3bXixBSFV6RKvUCXK2xPZs6bO1gbyLl1j_AiX_IL8FJStT2UE625nvZM3NaHPngsSheUjKhhDZvFhO3cHbCCCMTIidE8CfFCZWtrHhN6VG-M0KrrqXsuDhNaUEIEU0jnxXHnEnGZNOcFL_O7Rq8cX5eTi-_zz5UtCvXYHIBU_nn5ncJ6-DsFrau7zGiH8uI89UAY4ibMo3gLUSbyj7EO5SDRYZLj2h3eFii31XGCD4tYUe1MEKZriDmkOfF0x6GhC9uz7Pi26ePX6dfqovLz7Pp-UVlasLGijNdE9P3vG600CC0AY091qi1kIiZVCOXgF3T9g1tObON1dC3XDCJGpGfFbO9rw2wUMvoriFuVACndoUQ5wri6MyAqgbeEchRVnKh26YDqQWhIrcQaCdJ9nq_91qu9DVak_8UYbhneh_x7krNw1q1gtesa7LB61uDGH6uMI3q2iWDwwAewyopJngj8uhEnamv7mYdQv7NMxPYnmBiSClif6BQorZLoxZquzRquzSKSJWXJovkA5FxI4wubN_rhsel7_ZSzNNaO4wqGYfeoHURzZjb6R6Xv30gN4PzzsDwAzf_E_8F6J30jQ
CitedBy_id crossref_primary_10_22207_JPAM_16_1_37
crossref_primary_10_1016_j_jiph_2020_12_025
crossref_primary_10_5812_amh_120362
crossref_primary_10_1016_j_eswa_2022_118160
crossref_primary_10_1186_s12941_020_00384_w
crossref_primary_10_4103_injms_injms_86_21
crossref_primary_10_14260_jemds_2021_814
crossref_primary_10_1016_j_procs_2021_04_040
crossref_primary_10_2147_IDR_S288877
crossref_primary_10_1111_1758_5899_13081
Cites_doi 10.1056/NEJMp2005630
10.1080/21645515.2020.1735227
10.1097/01.inf.0000243193.93355.e5
10.1016/S0140-6736(13)60177-4
ContentType Journal Article
Copyright 2020 The Authors
2020 The Authors 2020
Copyright_xml – notice: 2020 The Authors
– notice: 2020 The Authors 2020
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1016/j.ijid.2020.08.043
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1878-3511
EndPage 502
ExternalDocumentID oai_doaj_org_article_5a390af35d834b769a8b4014328a1980
PMC7435296
32822866
10_1016_j_ijid_2020_08_043
S1201971220306755
Genre Editorial
Commentary
GroupedDBID ---
--K
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
29J
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7X7
88E
8C1
8FI
8FJ
8FQ
8R4
8R5
AAEDW
AAFWJ
AAIKJ
AALRI
AAQFI
AAQXK
AARKO
AAXUO
AAYWO
ABBQC
ABFRF
ABMAC
ABUWG
ABWVN
ACGFO
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFJKZ
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AGEKW
AGHFR
AGQPQ
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BCNDV
BENPR
BPHCQ
BR6
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
FYUFA
G-Q
GBLVA
GROUPED_DOAJ
GX1
HMCUK
HVGLF
HZ~
IHE
IXB
J1W
KQ8
M1P
M3C
M3G
M41
MO0
N9A
O-L
O9-
OD-
OK1
OO.
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q2X
Q38
QTD
R2-
ROL
RPZ
RWL
RXW
SDF
SDG
SEL
SES
SEW
SSZ
TAE
UKHRP
UNMZH
Z5R
0SF
3V.
6I.
AACTN
AAFTH
ABVKL
AFCTW
NCXOZ
RIG
AAYXX
ALIPV
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c502t-32b50cff356b4ba4bcabefe5ebb48eec505e38ae967f61732d6dbaf73428ebee3
IEDL.DBID .~1
ISSN 1201-9712
1878-3511
IngestDate Wed Aug 27 01:28:22 EDT 2025
Thu Aug 21 18:27:23 EDT 2025
Fri Jul 11 12:06:57 EDT 2025
Thu Apr 03 07:08:27 EDT 2025
Tue Jul 01 04:29:55 EDT 2025
Thu Apr 24 23:08:01 EDT 2025
Fri Feb 23 02:48:00 EST 2024
Tue Aug 26 16:33:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article under the CC BY-NC-ND license.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c502t-32b50cff356b4ba4bcabefe5ebb48eec505e38ae967f61732d6dbaf73428ebee3
Notes SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1201971220306755
PMID 32822866
PQID 2436400445
PQPubID 23479
PageCount 2
ParticipantIDs doaj_primary_oai_doaj_org_article_5a390af35d834b769a8b4014328a1980
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7435296
proquest_miscellaneous_2436400445
pubmed_primary_32822866
crossref_primary_10_1016_j_ijid_2020_08_043
crossref_citationtrail_10_1016_j_ijid_2020_08_043
elsevier_sciencedirect_doi_10_1016_j_ijid_2020_08_043
elsevier_clinicalkey_doi_10_1016_j_ijid_2020_08_043
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-09-01
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
PublicationTitle International journal of infectious diseases
PublicationTitleAlternate Int J Infect Dis
PublicationYear 2020
Publisher Elsevier Ltd
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
– name: Elsevier
References Washington Post (bib0045) 2020
Science. 2020. Science Russia’s approval of a COVID-19 vaccine is less than meets the press.-
Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. and the MVA85A 020 Trial Study Team. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013;381(9871):1021-8.
Lurie, Saville, Hatchett, Halton (bib0015) 2020; 382
Callaway (bib0005) 2020
Russia Ministry of Health. 2020.
accessed 15th August, 2020).
Dhama, Sharun, Tiwari (bib0010) 2020; 16
Prompetchara, Ketloy, Palaga (bib0020) 2020; 38
WHO (bib0050) 2020
WHO (bib0060) 2020
Staat, Cortese, Bresee, Bégué, Vitek, Rhodes (bib0035) 2006; 25
WHO (bib0055) 2020
Dhama (10.1016/j.ijid.2020.08.043_bib0010) 2020; 16
WHO (10.1016/j.ijid.2020.08.043_bib0055) 2020
10.1016/j.ijid.2020.08.043_bib0040
Washington Post (10.1016/j.ijid.2020.08.043_bib0045) 2020
Lurie (10.1016/j.ijid.2020.08.043_bib0015) 2020; 382
10.1016/j.ijid.2020.08.043_bib0030
Staat (10.1016/j.ijid.2020.08.043_bib0035) 2006; 25
WHO (10.1016/j.ijid.2020.08.043_bib0050) 2020
WHO (10.1016/j.ijid.2020.08.043_bib0060) 2020
Prompetchara (10.1016/j.ijid.2020.08.043_bib0020) 2020; 38
10.1016/j.ijid.2020.08.043_bib0025
Callaway (10.1016/j.ijid.2020.08.043_bib0005) 2020
References_xml – volume: 38
  start-page: 1
  year: 2020
  end-page: 9
  ident: bib0020
  article-title: Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
  publication-title: Asian Pac J Allergy Immunol
– volume: 25
  start-page: 1013
  year: 2006
  end-page: 1018
  ident: bib0035
  article-title: Rhesus rotavirus vaccine effectiveness and factors associated with receipt of vaccine
  publication-title: Pediatr Infect Dis J
– reference: -accessed 15th August, 2020).
– reference: - accessed 15th August, 2020).
– reference: Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. and the MVA85A 020 Trial Study Team. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013;381(9871):1021-8.
– year: 2020
  ident: bib0060
  article-title: More than 150 countries engaged in COVID-19 vaccine global access facility
– year: 2020
  ident: bib0045
  article-title: Scientists uneasy as Russia approves first coronavirus vaccine
– volume: 16
  start-page: 1232
  year: 2020
  end-page: 1238
  ident: bib0010
  article-title: COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
  publication-title: Hum Vaccin Immunother
– reference: Russia Ministry of Health. 2020.
– year: 2020
  ident: bib0055
  article-title: Draft Landscape of COVID-19 candidate vaccines
– year: 2020
  ident: bib0005
  article-title: Russia’s fast-track coronavirus vaccine draws outrage over safety [published online ahead of print, 2020 Aug 11]
  publication-title: Nature
– year: 2020
  ident: bib0050
  article-title: R&D Blueprint and COVID-19
– reference: Science. 2020. Science Russia’s approval of a COVID-19 vaccine is less than meets the press.-
– volume: 382
  start-page: 1969
  year: 2020
  end-page: 1973
  ident: bib0015
  article-title: Developing Covid-19 Vaccines at Pandemic Speed
  publication-title: N Engl J Med
– volume: 382
  start-page: 1969
  issue: May (21)
  year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0015
  article-title: Developing Covid-19 Vaccines at Pandemic Speed
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp2005630
– year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0045
– ident: 10.1016/j.ijid.2020.08.043_bib0025
– year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0055
– year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0050
– year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0005
  article-title: Russia’s fast-track coronavirus vaccine draws outrage over safety [published online ahead of print, 2020 Aug 11]
  publication-title: Nature
– year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0060
– volume: 16
  start-page: 1232
  issue: 6
  year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0010
  article-title: COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2020.1735227
– volume: 38
  start-page: 1
  issue: 1
  year: 2020
  ident: 10.1016/j.ijid.2020.08.043_bib0020
  article-title: Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
  publication-title: Asian Pac J Allergy Immunol
– ident: 10.1016/j.ijid.2020.08.043_bib0030
– volume: 25
  start-page: 1013
  year: 2006
  ident: 10.1016/j.ijid.2020.08.043_bib0035
  article-title: Rhesus rotavirus vaccine effectiveness and factors associated with receipt of vaccine
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/01.inf.0000243193.93355.e5
– ident: 10.1016/j.ijid.2020.08.043_bib0040
  doi: 10.1016/S0140-6736(13)60177-4
SSID ssj0004668
Score 2.3192184
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 501
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELaqHlAlhKAtsPzJlbghiyT-SfYIhapUarnQqjdrnDg0VZVFu2klbrwAJ96QJ2HGTqINSO2FWxSPHdkz8czYM98w9tq4tE5NVYtCmkooqKVwWemFhqQqnVOoYigb-fjEHJ6qo3N9vlbqi2LCIjxwXLi3GtArxyF0VUjlcjOHwikCpcsKQIc5eOuo8wZnasyIjElwqN7EPE-zPl0mRnY1lw1hhGZJAO9UcqKSAnL_RDP9a3n-HUC5ppEOHrIHvSnJ38UpPGIbvt1m9477y_Jtdj8eyfGYabTDfoYKytj2le9_Pvv0QaRzfgMlEa_47x-_ONwsGlJlfKia0vFlLFW_WH7nw6HDiqOdu0YyDoHNvEVlGNqpKld40wX0dAikFI7KVxdAZ4m77PTg45f9Q9FXYxClTrJOyMzppKyRE8YpB8qV4HzttUeOFt4jkfayAD83eY1mkcyoVBXUuUQHByXFy8dss120_injVZrUuHmkABq9GYU-DST4nDip0Zop5YylA0Ns2UOVU8WMKzvEpF1aYqIlJloqo6mwz5uxz7cI1HEr9Xvi80hJINvhBYqe7UXP3iV6MyYHKbFDHivuvDhQc-un9dirt3Ki9XJnv71BEC1uAXSvA61fXK9spqShrVjpGXsSBXOcmKQw4cKYGcsnIjuZ-bSlbS4CzDjalnQp_-x_LNVztkVTicF5L9hmt7z2L9Ga69yr8OP-AeTbR-4
  priority: 102
  providerName: Directory of Open Access Journals
Title Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1201971220306755
https://dx.doi.org/10.1016/j.ijid.2020.08.043
https://www.ncbi.nlm.nih.gov/pubmed/32822866
https://www.proquest.com/docview/2436400445
https://pubmed.ncbi.nlm.nih.gov/PMC7435296
https://doaj.org/article/5a390af35d834b769a8b4014328a1980
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhASQlBey6MyEjcUNo4fSY50S9UFFQ5QtDfLzjptKpRUu2mlXir-ACf-Ib-EGTuJNiAViUuUtcd5zbczY3sehLxSlpVMLcso42oZCVPyyCaFi6SJl4W1AlQMRiMffVSHx-L9Qi62yKyPhUG3yk72B5nupXXXMu2-5vS8qqafGeiuPGVJEsxeDDQXIkWUv7lmG7GRIRwOiCOk7gJngo9XdVZhttAk9mk8BR8pJ5_Df6Sj_rZB_3Sl3NBNB_fI3c6opG_Dc98nW67eIbeOum3zHXInLM7REHP0gPzwtZSh74TOPn2d70csp5emQOI1_fX9JzWXTYVKjfb1U1q6CkXrm9UV7Zcf1hQs3g2S4RLQTWtQi74f63P5ltbnUTeeFB1T6frU4KriQ3J88O7L7DDq6jJEhYyTNuKJlXFRllwqK6wRtjDWlU464G3mHBBJxzPjcpWWYCDxBItWmTLlMNUBzDj-iGzXTe2eELpkcQlihBkjYV4jYHZjYjiPLZdg1xR8QljPEF10ScuxdsY33XunnWlkokYmaiyoKWDM62HMeUjZcSP1HvJ5oMR0276hWZ3oDm9aGp7HgGO5zLiwqcpNZgVmRkwyw_IsnhDeo0T3Ea0gg-FC1Y23lsOoEeb_Oe5lD0QNwgB3eEztmou1TgRXKJSFnJDHAZjDi3F0GM6UmpB0BNnRm4976urUJxwHKxO355_-5_M-I7fxV_DMe06229WFewGmXGt3_X8VjvvzD7t-OQSO88XebwGBTJc
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0CpFAiSEoLyWp5HghMImfm1y4AAt1S7tlgMt6s21E2ebCiXV7raoF8QPcOJT-CO-hBknWW1AKhJSb5Fn7NiZ8czYmQchz5WN8khleRBzlQXC5DywLHWBNGGWWitAxWA08nhHDffE-325v0J-trEw6FbZyP5apntp3bT0m6_ZPy6K_scIdFcyiBirzd7Ws3LLnX2Bc9vs9WgDiPyCsc13u-vDoCktEKQyZPOAMyvDNM-5VFZYI2xqrMuddDC92DlAko7HxiVqkIOO5wzrLpl8wMFah2U7DuNeIpcFiAssm_Dqa7QUjFnH38HsApxeE6lTO5UVRwWmJ2WhzxsqeEcb-qIBHaX4t9H7p-_mkjLcvEluNFYsfVN_qFtkxZVr5Mq4-U-_Rq7Xt4G0DnK6Tb774s0Am9D1D59GG0GU0FOTIvKM_vr2g5rTqkAtStuCLXM6dRMsLVZNz2h73zGjYGIvoSyGADAtQQ97OBYE8y1zn7jdeFT0hKWzQ4PXmHfI3oVQ6y5ZLavS3Sc0i8Ic5FZkjISDlIDjlAnhObRcgiGV8h6JWoLotMmSjsU6PuvWHe5IIxE1ElFjBU8BfV4u-hzXOULOxX6LdF5gYn5v31BNJ7phcC0NT0LYODKLubADlZjYCkzFyGITJXHYI7zlEt2G0ILQh4GKc18tF706m-yf_Z61jKhB-uAvJVO66mSmmeAKtYCQPXKvZszFwjh6KMdK9cigw7KdlXchZXHoM5yDWYv-AA_-c75PydXh7nhbb492th6Sawip3QIfkdX59MQ9Bjtybp_4fUvJwUULit_aQInt
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancing+COVID-19+vaccines+%E2%80%93+avoiding+different+regulatory+standards+for+different+vaccines+and+need+for+open+and+transparent+data+sharing&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Petersen%2C+Eskild&rft.au=Wejse%2C+Christian&rft.au=Zumla%2C+Alimuddin&rft.date=2020-09-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.eissn=1878-3511&rft.volume=98&rft.spage=501&rft.epage=502&rft_id=info:doi/10.1016%2Fj.ijid.2020.08.043&rft.externalDocID=S1201971220306755
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon